SEC Form 4 · accession 0001237899-15-000003
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S Brown
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 5, 2015 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 24, 2014 | G | 2,000 | $0.00 | D | 18,349 | I | by Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $413.33 | Jan 2, 2015 | A | 10,838 | A | — | Jan 2, 2025 | Common Stock | 10,838 | 10,838 | D |
Explanation of responses
- F1The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.